Untargeted metabolomics analysis on kidney tissues from mice reveals potential hypoxia biomarkers. 2023

Muhammad Imran Sajid, and Francisco J Nunez, and Farideh Amirrad, and Moom Rahman Roosan, and Tom Vojtko, and Scott McCulloch, and Amal Alachkar, and Surya M Nauli
Department of Biomedical and Pharmaceutical Sciences, Chapman University, 9401 Jeronimo Road, Irvine, CA, 92618-1908, USA.

Chronic hypoxia may have a huge impact on the cardiovascular and renal systems. Advancements in microscopy, metabolomics, and bioinformatics provide opportunities to identify new biomarkers. In this study, we aimed at elucidating the metabolic alterations in kidney tissues induced by chronic hypoxia using untargeted metabolomic analyses. Reverse phase ultrahigh performance liquid chromatography-mass spectroscopy/mass spectroscopy (RP-UPLC-MS/MS) and hydrophilic interaction liquid chromatography (HILIC)-UPLC-MS/MS methods with positive and negative ion mode electrospray ionization were used for metabolic profiling. The metabolomic profiling revealed an increase in metabolites related to carnitine synthesis and purine metabolism. Additionally, there was a notable increase in bilirubin. Heme, N-acetyl-L-aspartic acid, thyroxine, and 3-beta-Hydroxy-5-cholestenoate were found to be significantly downregulated. 3-beta-Hydroxy-5-cholestenoate was downregulated more significantly in male than female kidneys. Trichome Staining also showed remarkable kidney fibrosis in mice subjected to chronic hypoxia. Our study offers potential intracellular metabolite signatures for hypoxic kidneys.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem
D055432 Metabolomics The systematic identification and quantitation of all the metabolic products of a cell, tissue, organ, or organism under varying conditions. The METABOLOME of a cell or organism is a dynamic collection of metabolites which represent its net response to current conditions. Metabonomics,Metabolomic,Metabonomic

Related Publications

Muhammad Imran Sajid, and Francisco J Nunez, and Farideh Amirrad, and Moom Rahman Roosan, and Tom Vojtko, and Scott McCulloch, and Amal Alachkar, and Surya M Nauli
January 2022, Frontiers in oncology,
Muhammad Imran Sajid, and Francisco J Nunez, and Farideh Amirrad, and Moom Rahman Roosan, and Tom Vojtko, and Scott McCulloch, and Amal Alachkar, and Surya M Nauli
February 2023, Clinica chimica acta; international journal of clinical chemistry,
Muhammad Imran Sajid, and Francisco J Nunez, and Farideh Amirrad, and Moom Rahman Roosan, and Tom Vojtko, and Scott McCulloch, and Amal Alachkar, and Surya M Nauli
December 2022, Metabolites,
Muhammad Imran Sajid, and Francisco J Nunez, and Farideh Amirrad, and Moom Rahman Roosan, and Tom Vojtko, and Scott McCulloch, and Amal Alachkar, and Surya M Nauli
December 2022, International journal of molecular sciences,
Muhammad Imran Sajid, and Francisco J Nunez, and Farideh Amirrad, and Moom Rahman Roosan, and Tom Vojtko, and Scott McCulloch, and Amal Alachkar, and Surya M Nauli
January 2021, Clinical and experimental rheumatology,
Muhammad Imran Sajid, and Francisco J Nunez, and Farideh Amirrad, and Moom Rahman Roosan, and Tom Vojtko, and Scott McCulloch, and Amal Alachkar, and Surya M Nauli
November 2023, Natural product research,
Muhammad Imran Sajid, and Francisco J Nunez, and Farideh Amirrad, and Moom Rahman Roosan, and Tom Vojtko, and Scott McCulloch, and Amal Alachkar, and Surya M Nauli
December 2023, BMC cancer,
Muhammad Imran Sajid, and Francisco J Nunez, and Farideh Amirrad, and Moom Rahman Roosan, and Tom Vojtko, and Scott McCulloch, and Amal Alachkar, and Surya M Nauli
March 2024, Biomedical chromatography : BMC,
Muhammad Imran Sajid, and Francisco J Nunez, and Farideh Amirrad, and Moom Rahman Roosan, and Tom Vojtko, and Scott McCulloch, and Amal Alachkar, and Surya M Nauli
November 2022, Journal of personalized medicine,
Muhammad Imran Sajid, and Francisco J Nunez, and Farideh Amirrad, and Moom Rahman Roosan, and Tom Vojtko, and Scott McCulloch, and Amal Alachkar, and Surya M Nauli
September 2023, Clinical and experimental medicine,
Copied contents to your clipboard!